| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |